Tumor DNA analysis aims to speed up enrollment in early cancer trials

NCT ID NCT04510766

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will analyze genetic material from stored tumor samples of 40 adults with advanced solid tumors or lymphoma. The goal is to see if molecular profiling can help identify more patients for early phase clinical trials. Researchers will track how many patients with a genetic profile are enrolled per year and what types of mutations are found.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help match more patients to early phase trials based on their tumor's genetic profile.

What could go wrong

This is a small, observational study that does not test a treatment. It may not lead to direct benefits for participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lymphoma neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oncology Institute of Southern Switzerland

    RECRUITING

    Bellinzona, 6500, Switzerland

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact